Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of IFN-I pathway activation may have clinical value. Although several IFN-I pathway assays have been proposed, the exact clinical appl...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Mary K Crow, Lars Rönnblom, Dimitrios T Boumpas, Robert Biesen, George Bertsias, Marie-Louise Frémond, Marie Wahren-Herlenius, Giulio Cavalli, Maija-Leena Eloranta, Javier Rodríguez-Carrio, Marianne Visser, P G Conaghan, Agata Burska, Willem A Dik, Ed Vital, Jan Rehwinkel, Marjan Versnel
Format:	Artigo
Język:	Inglês
Wydane:	BMJ Publishing Group 2023-03-01
Seria:	RMD Open
Dostęp online:	https://rmdopen.bmj.com/content/9/1/e002864.full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!